Sarepta Therapeutics (SRPT) Shares Outstanding (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Shares Outstanding (Entity) of $105.0 million for Q1 2026, up 7.83% year-over-year from $97.4 million in Q1 2025, and up 4.86% quarter-over-quarter from $100.1 million in Q4 2025.
Sarepta Therapeutics (SRPT) Shares Outstanding (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $105.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 7.83% year-over-year to $105.0 million; the TTM figure through Mar 2026 stood at $105.0 million (up 7.83% YoY), while the FY2025 annual figure was $100.1 million, up 5.31% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $105.0 million, up from $100.1 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $105.4 million in Q3 2025, with the low at $87253.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $94.5 million (2024), against an average of $80.6 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) sank 99.89% in 2022, then jumped 106647.05% in 2023.
- Sarepta Therapeutics' Shares Outstanding (Entity) stood at $88.0 million in 2022, then advanced by 6.57% to $93.7 million in 2023, then rose by 1.43% to $95.1 million in 2024, then rose by 5.31% to $100.1 million in 2025, then advanced by 4.86% to $105.0 million in 2026.
- Business Quant data shows SRPT's Shares Outstanding (Entity) at $105.0 million in Q1 2026, $100.1 million in Q4 2025, and $105.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 105.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.43 Mn |
| Mar 31, 2026 | 104.99 Mn |
| Dec 31, 2025 | 100.12 Mn |
| Sep 30, 2025 | 100.24 Mn |
| Jun 30, 2025 | 98.01 Mn |
| Mar 31, 2025 | 97.36 Mn |
| Dec 31, 2024 | 95.08 Mn |
| Sep 30, 2024 | 95.39 Mn |
| Jun 30, 2024 | 94.62 Mn |
| Mar 31, 2024 | 93.99 Mn |
| Dec 31, 2023 | 92.40 Mn |
| Sep 30, 2023 | 88.89 Mn |
| Jun 30, 2023 | 88.74 Mn |
| Mar 31, 2023 | 88.19 Mn |
| Dec 31, 2022 | 87.56 Mn |
| Sep 30, 2022 | 11.20 Mn |
| Jun 30, 2022 | 11.30 Mn |
| Mar 31, 2022 | 87,253.00 |
| Dec 31, 2021 | 81.26 Mn |
| Sep 30, 2021 | 79,880.00 |